FDA Announces Nationwide Correction of Breas Medical Ventilators Due to Formaldehyde Exposure Risk
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced that Breas Medical is initiating a nationwide correction of 8,186 Vivo 45 LS ventilator devices. Internal testing identified the …
FDA Announces Nationwide Correction of Breas Medical Ventilators Due to Formaldehyde Exposure Risk Read More